美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Global Partners Lp

42.30

-1.1600-2.67%

盤後：42.300.00000.00%16:29 EST

成交量：3.30萬

成交額：140.45萬

市值：14.38億

市盈率：16.27

高：43.50

開：43.20

低：42.00

收：43.46

52周最高：60.00

52周最低：39.70

股本：3,399.56萬

流通股本：2,767.42萬

量比：0.31

換手率：0.12%

股息：2.97

股息率：7.02%

每股收益(TTM):2.60

每股收益(LYR):2.45

淨資產收益率：16.33%

總資產收益率：4.09%

市淨率：2.35

市盈率(LYR):17.29

資料載入中...

總覽公司新聞資訊公告

大行評級｜傑富瑞：上調聯邦制藥目標價至20港元維持「買入」評級

四環醫藥(00460)：惠升生物自研GLP-1R/GCGR雙靶點創新藥P052注射液獲批IND

新藥戰略瞄準GLP-1藥物，去年以來7款新藥在美團首發

广州日报新花城

電商平台成GLP-1藥物上市重要渠道

广州日报新花城

首款減肥GLP-1仿製藥獲批，壓力給到減重巨頭

恆瑞醫藥：HRS-4729注射液臨牀試驗獲批

開源證券：Orforglipron領跑全球小分子GLP-1RA賽道國內管線價值逐漸凸顯

歌禮制藥-B(01672)將在第61屆歐洲糖尿病研究協會(EASD)年會上報告ASC30 口服小分子GLP-1R激動劑28天多劑量遞增研究結果

大行評級｜里昂：上調阿里健康目標價至6.5港元維持「跑贏大市」評級

減重賽道全球前沿進展跟蹤(二)：ORFORGLIPRON領跑全球小分子GLP-1RA賽道國內管線價值逐漸凸顯

司美格魯肽最新臨牀數據出爐！GLP-1戰火延伸至心血管賽道

21世纪经济报道

在GLP-1（胰高血糖素樣肽-1）減肥藥的競爭中諾和諾德的司美格魯肽終於憑藉心血管方面的獲益扳回一局。9月1日記者從諾和

禮來終止2項口服GLP-1藥二期試驗

生物药大时代

禮來口服GLP-1藥物orforglipron III期研究成功

誰在網購減重版GLP-1？京東健康：90後購買量排第一，未來電商渠道預計超過七成

映恩生物上半年調整後利潤1.46億元，現金37.47億元；禮來口服GLP-1一項3期臨牀成功

Ofweek维科网

Viking Therapeutics股價下跌3.8%競爭對手禮來的GLP - 1藥片在糖尿病患者後期研究中助力減輕體重

禮來公司（Eli Lilly）在晚期試驗中發現其GLP - 1片劑使2型糖尿病患者體重減輕10.5%該公司股價上漲3.2

禮來公佈口服GLP-1RA III期臨牀結果，肥胖適應症預計今年在美提交

禮來公司週二表示其每日服用的減肥藥丸在後期試驗中幫助肥胖和2型糖尿病患者減輕了體重達到了研究的主要目標為該公司在全球範圍

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GLP/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"Global Partners Lp","latestPrice":42.3,"timestamp":1763413200000,"preClose":43.46,"halted":0,"volume":32986,"hourTrading":{"tag":"盘后","latestPrice":42.3,"preClose":42.3,"latestTime":"16:29 EST","volume":2601,"amount":110025.05,"timestamp":1763414986170},"delay":0,"floatShares":27674174,"shares":33995563,"eps":2.600398,"marketStatus":"已收盤","change":-1.16,"latestTime":"11-17 16:00:00 EST","open":43.2,"high":43.5,"low":42,"amount":1404540.4006,"amplitude":0.034514,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.600398,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1763456400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":43.46,"dividendRate":0.070213,"postHourTrading":{"tag":"盘后","latestPrice":42.3,"preClose":42.3,"latestTime":"16:29 EST","volume":2601,"amount":110025.05,"timestamp":1763414986170},"volumeRatio":0.311864,"impliedVol":0.4272,"impliedVolPercentile":0.76},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":27674174,"roa":"4.09%","roe":"16.33%","lyrEps":2.44604,"volumeRatio":0.311864,"shares":33995563,"dividePrice":2.97,"high":43.5,"amplitude":0.034514,"preClose":43.46,"low":42,"week52Low":39.7,"pbRate":"2.35","psRate":"0.08","week52High":60,"institutionHeld":0.4647,"latestPrice":42.3,"eps":2.600398,"divideRate":0.070213,"volume":32986,"delay":0,"ttmEps":2.600398,"open":43.2,"prevYearClose":46.55,"prevWeekClose":43.46,"prevMonthClose":45.21,"prevQuarterClose":48,"fiveDayClose":40.68,"twentyDayClose":45.22,"sixtyDayClose":50.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"date":"2025-11-10","symbol":"GLP","amount":0.755,"announcedDate":"2025-10-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-10","defaultRemindTime":1762785000000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-14","payableDate":"2025-11-10","currency":"USD","dateTimestamp":1762750800000,"payDate":"2025-11-14"},{"market":"US","date":"2025-11-07","symbol":"GLP","fiscalQuarterEnding":"2025/09","expectedEps":1.09,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.66},{"date":"2025-08-08","symbol":"GLP","amount":0.75,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-08","defaultRemindTime":1754659800000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-08-08","currency":"USD","dateTimestamp":1754625600000,"payDate":"2025-08-14"},{"market":"US","date":"2025-08-07","symbol":"GLP","fiscalQuarterEnding":"2025/06","expectedEps":0.6,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.55},{"date":"2025-05-09","symbol":"GLP","amount":0.745,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-09","defaultRemindTime":1746797400000,"name":"Global Partners Lp","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-15","payableDate":"2025-05-09","currency":"USD","dateTimestamp":1746763200000,"payDate":"2025-05-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-08-04","recordDate":"2016-08-08","paymentDate":"2016-08-12","value":0.4625,"currency":"USD"},{"executeDate":"2016-11-04","recordDate":"2016-11-08","paymentDate":"2016-11-14","value":0.4625,"currency":"USD"},{"executeDate":"2017-02-07","recordDate":"2017-02-09","paymentDate":"2017-02-14","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741237200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-11-14","current":16.289814,"percent":0.861958,"low":2.771386,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"high":29.34912,"avg":11.439205,"sd":6.349914,"marketCap":1432862540},"quantilePoints":[{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":15.403069,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1642136538},{"date":"2024-06-07","current":15.399881,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1641796762},{"date":"2024-06-14","current":15.042931,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1603741870},{"date":"2024-06-21","current":14.389583,"twenty":4.452456,"median":8.72747,"eighty":13.257384,"marketCap":1534087827},{"date":"2024-06-28","current":14.542562,"twenty":4.452456,"median":8.72747,"eighty":13.270766,"marketCap":1550397066},{"date":"2024-07-05","current":14.395957,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1534767378},{"date":"2024-07-12","current":13.586443,"twenty":4.452456,"median":8.72747,"eighty":13.285322,"marketCap":1448464320},{"date":"2024-07-19","current":12.767369,"twenty":4.452456,"median":8.72747,"eighty":13.228966,"marketCap":1361141934},{"date":"2024-07-26","current":12.910786,"twenty":4.452456,"median":8.72747,"eighty":13.052045,"marketCap":1376431846},{"date":"2024-08-02","current":13.302795,"twenty":4.452456,"median":8.72747,"eighty":12.924809,"marketCap":1418224272},{"date":"2024-08-09","current":12.449802,"twenty":4.452456,"median":8.72747,"eighty":12.75462,"marketCap":1335540014},{"date":"2024-08-16","current":13.196601,"twenty":4.452456,"median":8.72747,"eighty":12.789678,"marketCap":1415652134},{"date":"2024-08-23","current":13.473893,"twenty":4.452456,"median":8.72747,"eighty":13.02799,"marketCap":1445398406},{"date":"2024-08-30","current":14.204937,"twenty":4.452456,"median":8.72747,"eighty":13.191559,"marketCap":1523820396},{"date":"2024-09-06","current":13.316341,"twenty":4.452456,"median":8.72747,"eighty":13.222287,"marketCap":1428497115},{"date":"2024-09-13","current":13.558971,"twenty":4.452456,"median":8.72747,"eighty":13.305504,"marketCap":1454525103},{"date":"2024-09-20","current":14.226994,"twenty":4.452456,"median":8.72747,"eighty":13.395117,"marketCap":1526186577},{"date":"2024-09-27","current":14.085197,"twenty":4.452456,"median":8.72747,"eighty":13.544476,"marketCap":1510975415},{"date":"2024-10-04","current":14.976944,"twenty":4.452456,"median":8.72747,"eighty":13.679972,"marketCap":1606636722},{"date":"2024-10-11","current":14.803637,"twenty":4.452456,"median":8.72747,"eighty":13.85562,"marketCap":1588045302},{"date":"2024-10-18","current":14.529495,"twenty":4.452456,"median":8.72747,"eighty":14.019655,"marketCap":1558637056},{"date":"2024-10-25","current":14.772126,"twenty":4.452456,"median":8.72747,"eighty":14.168401,"marketCap":1584665044},{"date":"2024-11-01","current":14.778428,"twenty":4.452456,"median":8.72747,"eighty":14.27768,"marketCap":1585341095},{"date":"2024-11-08","current":13.141823,"twenty":4.452456,"median":8.73918,"eighty":14.377354,"marketCap":1640493731},{"date":"2024-11-15","current":13.379586,"twenty":4.452456,"median":8.78252,"eighty":14.377354,"marketCap":1670173717},{"date":"2024-11-22","current":14.322533,"twenty":4.452456,"median":8.81344,"eighty":14.377354,"marketCap":1787881840},{"date":"2024-11-29","current":15.251971,"twenty":4.452456,"median":8.883858,"eighty":14.399781,"marketCap":1903903601},{"date":"2024-12-06","current":15.273586,"twenty":4.452456,"median":8.934183,"eighty":14.482822,"marketCap":1906601781},{"date":"2024-12-13","current":14.4198,"twenty":4.452456,"median":9.012663,"eighty":14.537463,"marketCap":1800023652},{"date":"2024-12-20","current":12.93378,"twenty":4.452456,"median":9.090449,"eighty":14.537463,"marketCap":1614523744},{"date":"2024-12-27","current":12.995923,"twenty":4.452456,"median":9.19602,"eighty":14.537463,"marketCap":1622281013},{"date":"2025-01-03","current":12.766265,"twenty":4.452456,"median":9.268408,"eighty":14.537463,"marketCap":1593612846},{"date":"2025-01-10","current":12.631172,"twenty":4.448612,"median":9.31881,"eighty":14.538738,"marketCap":1576749218},{"date":"2025-01-17","current":14.282006,"twenty":4.448612,"median":9.382279,"eighty":14.538738,"marketCap":1782822752},{"date":"2025-01-24","current":13.892938,"twenty":4.448612,"median":9.455255,"eighty":14.538738,"marketCap":1734255503},{"date":"2025-01-31","current":14.63865,"twenty":4.448612,"median":9.481129,"eighty":14.558635,"marketCap":1827342730},{"date":"2025-02-07","current":15.684268,"twenty":4.448612,"median":9.514397,"eighty":14.63454,"marketCap":1957867210},{"date":"2025-02-14","current":15.462716,"twenty":4.448612,"median":9.568033,"eighty":14.675959,"marketCap":1930210860},{"date":"2025-02-21","current":15.732902,"twenty":4.448612,"median":9.580931,"eighty":14.694621,"marketCap":1963938116},{"date":"2025-02-28","current":20.937616,"twenty":4.448612,"median":9.626092,"eighty":14.774647,"marketCap":1933567942},{"date":"2025-03-07","current":19.49754,"twenty":4.444767,"median":9.675026,"eighty":14.838928,"marketCap":1800578330},{"date":"2025-03-14","current":19.960552,"twenty":4.444767,"median":9.675026,"eighty":14.901539,"marketCap":1843337016},{"date":"2025-03-21","current":19.362647,"twenty":4.444767,"median":9.689317,"eighty":15.017908,"marketCap":1788121076},{"date":"2025-03-28","current":19.698057,"twenty":4.444767,"median":9.708699,"eighty":15.110765,"marketCap":1819095871},{"date":"2025-04-04","current":17.87153,"twenty":4.444767,"median":9.75606,"eighty":15.125044,"marketCap":1650417909},{"date":"2025-04-11","current":17.576223,"twenty":4.448612,"median":9.799015,"eighty":15.243459,"marketCap":1623146621},{"date":"2025-04-17","current":18.509538,"twenty":4.448612,"median":9.802712,"eighty":15.283315,"marketCap":1709337357},{"date":"2025-04-25","current":18.910572,"twenty":4.444767,"median":9.80686,"eighty":15.360398,"marketCap":1746372438},{"date":"2025-05-02","current":18.710055,"twenty":4.444767,"median":9.80686,"eighty":15.401794,"marketCap":1727854897},{"date":"2025-05-09","current":14.05872,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1621799891},{"date":"2025-05-16","current":14.406029,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1661865116},{"date":"2025-05-23","current":14.373925,"twenty":4.444767,"median":9.80686,"eighty":15.43196,"marketCap":1658161608},{"date":"2025-05-30","current":15.450609,"twenty":4.444767,"median":9.80686,"eighty":15.444645,"marketCap":1782366767},{"date":"2025-06-06","current":15.621074,"twenty":4.444767,"median":9.80686,"eighty":15.514776,"marketCap":1802031456},{"date":"2025-06-13","current":16.520424,"twenty":4.444767,"median":9.80686,"eighty":15.572999,"marketCap":1905779645},{"date":"2025-06-20","current":16.170677,"twenty":4.440923,"median":9.804164,"eighty":15.627805,"marketCap":1865433127},{"date":"2025-06-27","current":15.57111,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1796267668},{"date":"2025-07-03","current":15.479999,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1785757230},{"date":"2025-07-11","current":15.432974,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1780332488},{"date":"2025-07-18","current":14.992116,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1729475533},{"date":"2025-07-25","current":15.333047,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1768804912},{"date":"2025-08-01","current":15.430035,"twenty":4.440923,"median":9.804164,"eighty":15.665123,"marketCap":1779993442},{"date":"2025-08-08","current":17.700627,"twenty":4.440923,"median":9.82349,"eighty":15.67238,"marketCap":1703526003},{"date":"2025-08-15","current":17.97186,"twenty":4.440923,"median":9.917298,"eighty":15.726991,"marketCap":1729629785},{"date":"2025-08-22","current":17.975383,"twenty":4.440923,"median":9.97212,"eighty":15.765277,"marketCap":1729968795},{"date":"2025-08-29","current":18.669318,"twenty":4.440923,"median":10.032501,"eighty":15.848057,"marketCap":1796753795},{"date":"2025-09-05","current":18.391039,"twenty":4.437079,"median":10.161405,"eighty":15.873833,"marketCap":1769971993},{"date":"2025-09-12","current":18.229004,"twenty":4.440923,"median":10.244717,"eighty":15.951577,"marketCap":1754377526},{"date":"2025-09-19","current":17.911977,"twenty":4.440923,"median":10.348339,"eighty":16.07924,"marketCap":1723866612},{"date":"2025-09-26","current":17.668924,"twenty":4.440923,"median":10.483035,"eighty":16.238322,"marketCap":1700474912},{"date":"2025-10-03","current":16.622738,"twenty":4.440923,"median":10.565798,"eighty":16.310589,"marketCap":1599788897},{"date":"2025-10-10","current":15.678704,"twenty":4.440923,"median":10.601474,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-10-17","current":15.460308,"twenty":4.440923,"median":10.638631,"eighty":16.329708,"marketCap":1487915548},{"date":"2025-10-24","current":16.192991,"twenty":4.440923,"median":10.724558,"eighty":16.329708,"marketCap":1558429659},{"date":"2025-10-31","current":15.978118,"twenty":4.440923,"median":10.745006,"eighty":16.329708,"marketCap":1537750040},{"date":"2025-11-07","current":15.678704,"twenty":4.440923,"median":10.777877,"eighty":16.329708,"marketCap":1508934177},{"date":"2025-11-14","current":18.215203,"twenty":4.440923,"median":10.808766,"eighty":16.403793,"marketCap":1432862540}],"updateTime":1763409130350},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566903654","title":"大行評級｜傑富瑞：上調聯邦制藥目標價至20港元 維持「買入」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2566903654","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566903654?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 10:05","pubTimestamp":1757383541,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0154236417.USD","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","BK1574","GLP","BK4599","IE00BZ1G4Q59.USD","159992","LU1093756168.USD","NVO","BK4144","03933","BK4588","BK1161","BK4585","BK4532","BK4590","BK1191","06978"],"gpt_icon":0},{"id":"2566655238","title":"四環醫藥(00460)：惠升生物自研GLP-1R/GCGR雙靶點創新藥P052注射液獲批IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2566655238","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566655238?lang=zh_tw&edition=fundamental","pubTime":"2025-09-09 08:13","pubTimestamp":1757376814,"startTime":"0","endTime":"0","summary":"临床前数据显示，GLP-1R/GCGR双靶点创新药P052注射液的降糖效果与GLP-1单靶点药物司美格鲁肽注射液相似，减重效果显著优于司美格鲁肽注射液。糖尿病领域为惠升生物重点布局领域，本次GLP-1R/GCGR双靶点激动剂创新药P052注射液获批IND，不仅是惠升生物创新研发实力的有力证明，也意味着惠升生物在糖尿病药物研发方面迈出了重要的一步，为集团糖尿病业务长期发展注入动能，进一步提升在糖尿病行业的核心竞争力与市场价值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1600","00460","BK1574","BK1593","BK1515","BK4590","GLP","BK1191","BK1161","BK4144","159992","06978"],"gpt_icon":0},{"id":"2565521690","title":"新藥戰略瞄準GLP-1藥物，去年以來7款新藥在美團首發","url":"https://stock-news.laohu8.com/highlight/detail?id=2565521690","media":"广州日报新花城","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565521690?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 01:12","pubTimestamp":1757265176,"startTime":"0","endTime":"0","summary":"据悉，GLP-1药物属于美团新药战略的一部分。从去年以来，已陆续有7款新药在美团首发，包括[美欧品]兴齐硫酸阿托品0.01%滴眼液、[诺和盈]司美格鲁肽、[诺和忻]司美格鲁肽、[穆峰达]替尔泊肽、[信尔美]玛仕度肽、[优乐思]多替诺雷，[达卫可]莱博雷生等，涵盖GLP-1、近视、痛风、抗失眠等领域。以莱博雷生为例，作为目前唯一可以通过线上平台购买的安眠药，价格不算低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509083506942086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0605514214.HKD","LU1868837565.USD","LU0417516738.SGD","LU0700851271.USD","LU0499858438.USD","LU0501845795.SGD","LU0348825331.USD","LU0633140727.USD","LU0683595622.HKD","LU0868486357.SGD","LU2242644610.SGD","LU0314109678.HKD","LU1224709979.USD","LU0561508036.HKD","BK1521","LU0918141705.HKD","LU1282648689.USD","LU0326948709.USD","LU0181495838.USD","BK1610","HMTD.SI","LU0823426308.USD","LU0589944569.HKD","LU0821914370.USD","03690","LU0054450605.USD","BK1615","LU1807302812.USD","LU1813983027.USD","LU0672654166.SGD","METmain","LU0231483743.USD","MPNGY","LU1868837722.USD","IE0032431581.USD","IE00BF5LJ272.USD","LU0588545490.SGD","LU0650527681.SGD","LU1808992512.USD","LU2226246903.HKD","LU1481107354.HKD","LU0797268264.HKD","LU2039709279.SGD","GLP","IE0034224299.USD","LU0048580855.USD","LU0502904849.HKD","LU0823041008.USD","LU2097828805.USD","LU0359201612.USD"],"gpt_icon":0},{"id":"2565567983","title":"電商平台成GLP-1藥物上市重要渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2565567983","media":"广州日报新花城","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565567983?lang=zh_tw&edition=fundamental","pubTime":"2025-09-06 01:14","pubTimestamp":1757092480,"startTime":"0","endTime":"0","summary":"GLP-1药物竞争激烈，电商平台成为重要销售渠道。据一位行业人士透露，GLP-1药物在美团平台上销售表现突出：“从2023年以来，美团平台上GLP-1药物的订单规模已达200万单，订单主要来自于自营大药房。”据悉，美团平台GLP-1药物中，礼来的替尔泊肽表现最为亮眼，自去年年底上市以来，目前平台上的订单规模已经超过50万单。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509063506487529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"2564728423","title":"首款減肥GLP-1仿製藥獲批，壓力給到減重巨頭","url":"https://stock-news.laohu8.com/highlight/detail?id=2564728423","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564728423?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 19:28","pubTimestamp":1756985314,"startTime":"0","endTime":"0","summary":"美东时间2025年8月28日，FDA批准梯瓦制药生产利拉鲁肽注射液仿制药），这标志着首个用于减肥的GLP-1受体激动剂仿制药正式问世。去年12月，梯瓦已获得诺和诺德另一利拉鲁肽药品 Victoza 的仿制药批准，用于治疗 2 型糖尿病。利拉鲁肽作为一种 GLP-1 受体激动剂，在诺和诺德的药物管线中具有重要地位。梯瓦仿制药的获批与上市，给了面临严峻市场挑战的诺和诺德新的压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904200203a4b3e651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904200203a4b3e651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","LU0154236417.USD","IE00BKVL7J92.USD","BK4588","O","GLP","BK4599","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVO","LU1093756168.USD","BK4144","BK4590","BK4532"],"gpt_icon":1},{"id":"2564437839","title":"恆瑞醫藥：HRS-4729注射液臨牀試驗獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2564437839","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564437839?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 17:42","pubTimestamp":1756978949,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6c3a5693ea3d090542e8eeb58c2c33eb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4590","BK0188","LU0359202008.SGD","159938","LU0405327494.USD","LU1064130708.USD","LU2328871848.SGD","600276","LU1655091616.SGD","LU0359201612.USD","BK4160","01276","LU2543165471.USD","GLP","BK1161","09939","BK1191","GIPR","LU1969619763.USD","BK1574","LU1255011170.USD","LU2580892789.USD","BK0060","LU1997245094.SGD","BK0239","BK4144","BK0183","LU2488822045.USD","BK0028","BK0196","LU0405327148.USD","LU2580892862.HKD","LU1023057109.AUD","LU1064131003.USD","LU2495084118.USD","BK0012","BK1515","LU2148510915.USD","LU0359201885.HKD","LU1997245177.USD","LU1328615791.USD","LU1997244956.HKD"],"gpt_icon":0},{"id":"2564330034","title":"開源證券：Orforglipron領跑全球小分子GLP-1RA賽道 國內管線價值逐漸凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2564330034","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564330034?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 09:34","pubTimestamp":1756863255,"startTime":"0","endTime":"0","summary":"国内小分子GLP-1RA赛道硕果累累，部分管线具备较强出海潜力，相关标的有望受益。Orforglipron已有3个III期临床达到主要终点，充分验证其安全性，而减肥疗效不及市场预期。国产小分子GLP-1RA通过结构优化与技术改进，疗效有望实现超越，临床开发潜力与商业化价值正持续凸显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","GLP","BK4144","BK4590"],"gpt_icon":0},{"id":"2564180806","title":"歌禮制藥-B(01672)將在第61屆歐洲糖尿病研究協會(EASD)年會上報告ASC30 口服小分子GLP-1R激動劑28天多劑量遞增研究結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2564180806","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564180806?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 17:47","pubTimestamp":1756806434,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，将在奥地利维也纳举行的第61届欧洲糖尿病研究协会年会上的简短口头讨论中报告ASC30口服小分子GLP-1受体激动剂28天多剂量递增研究数据。ASC30是一款正在临床研究中的小分子GLP-1R偏向激动剂，具有独特和差异化性质，使得同一小分子同时适用于口服片剂和皮下注射给药成为可能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4590","01672","BK1515","BK1161","GLP","BK1191","BK1574","BK4144","01477"],"gpt_icon":0},{"id":"2564873378","title":"大行評級｜里昂：上調阿里健康目標價至6.5港元 維持「跑贏大市」評級","url":"https://stock-news.laohu8.com/highlight/detail?id=2564873378","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564873378?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 13:35","pubTimestamp":1756791324,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"77428d2317be65ce005af08f46b92859","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1591","LU0456827905.SGD","BK1247","BK4590","BK1610","BK1584","BK1161","GLP","159992","86618","LU0051755006.USD","BK1502","BK1142","BK1583","06618","BK4144","00241","BK1617","BK1574","BK1515","BK1571","BK1189","06978","BK1615","BK1589","BK1501"],"gpt_icon":0},{"id":"2564805375","title":"減重賽道全球前沿進展跟蹤(二)：ORFORGLIPRON領跑全球小分子GLP-1RA賽道 國內管線價值逐漸凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2564805375","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564805375?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 00:00","pubTimestamp":1756742400,"startTime":"0","endTime":"0","summary":"国产小分子GLP-1RA 通过结构优化与技术改进，疗效有望实现超越，临床开发潜力与商业化价值正持续凸显。药代动力学特征或成为影响小分子GLP-1RA 疗效重要一环药代动力学特征可能是影响小分子GLP-1RA 疗效的重要一环。投资建议小分子GLP-1RA 有望为减重降糖市场提供新的增量空间。国内小分子GLP-1RA 赛道硕果累累，部分管线具备较强出海潜力，相关标的有望受益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902181146a4af790b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902181146a4af790b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2471134796.USD","LU2237443622.USD","BK4534","IE00BJJMRZ35.SGD","LU0323591593.USD","LU0823434583.USD","LU2236285917.USD","LU0203201768.USD","LU0097036916.USD","LU0320765992.SGD","LU1551013425.SGD","LU0385154629.USD","LU0256863902.USD","LU1814569148.SGD","LU0096364046.USD","SG9999014906.USD","LU1989771016.USD","LU2552382132.HKD","LU0471298694.HKD","LU1366192091.USD","SGXZ57979304.SGD","LU0079474960.USD","LU0094547139.USD","LU2237443549.SGD","SG9999014898.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1868837300.USD","SG9999017495.SGD","LU0316494557.USD","SGXZ81514606.USD","LU1061106388.HKD","SGXZ51526630.SGD","LU0471298777.SGD","LU0689472784.USD","LU1093756168.USD","SG9999015978.USD","LU2750360997.AUD","LU1868836757.USD","Y","GLP","LLY","LU2552382058.USD","LU0234572021.USD","LU1623119135.USD","LU2237438978.USD","LU0320765059.SGD","LU2602419157.SGD","BK4533","LU2237443465.HKD","LU1551013342.USD"],"gpt_icon":1},{"id":"2564904118","title":"司美格魯肽最新臨牀數據出爐！GLP-1戰火延伸至心血管賽道","url":"https://stock-news.laohu8.com/highlight/detail?id=2564904118","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564904118?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 16:32","pubTimestamp":1756715572,"startTime":"0","endTime":"0","summary":"【司美格鲁肽最新临床数据出炉！GLP-1战火延伸至心血管赛道】近日，诺和诺德在西班牙马德里举行的2025年欧洲心脏病学会（ESC）年会上公布了STEER真实世界研究的最新数据。该研究基于患者真实用药经历，评估了Wegovy（司美格鲁肽2.4 mg）对比替尔泊肽在超重或肥胖且已确诊心血管疾病但无糖尿病的患者中预防主要不良心血管事件（MACE）的有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509013501076534.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509013501076534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4590","BK4144"],"gpt_icon":0},{"id":"2564807899","title":"在GLP-1（胰高血糖素樣肽-1）減肥藥的競爭中諾和諾德的司美格魯肽終於憑藉心血管方面的獲益扳回一局。9月1日記者從諾和","url":"https://stock-news.laohu8.com/highlight/detail?id=2564807899","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564807899?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 14:33","pubTimestamp":1756708413,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756168.USD","MACE","BK4157","IE00BZ1G4Q59.USD","BK4590","LU0154236417.USD","LU1093756325.SGD","BK4599","BK4144","BK4532","BK4585","IE00BKVL7J92.USD","GLP","BK4588","BK4007","NVO","BK4183"],"gpt_icon":0},{"id":"2564862445","title":"禮來終止2項口服GLP-1藥二期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2564862445","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564862445?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 09:40","pubTimestamp":1756690859,"startTime":"0","endTime":"0","summary":"不过，备受关注的口服GLP-1药物orforglipron在三期临床中疗效未达预期。HRS9531是一款恒瑞自主研发的GLP-1/GIP双受体激动剂，该药已在中国开展多项临床试验，累计超过2000名受试者接受了治疗。图：恒瑞医药 部分研发管线歌礼制药口服小分子GLP-1激动剂ASC30在美国Ib期MAD队列2经安慰剂校准后的体重相对基线平均下降6.5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901104047a7084c86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901104047a7084c86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2462157665.USD","SG9999001176.SGD","LU0323591593.USD","IE00B2B36J28.USD","LU0882574139.USD","LU2237443382.USD","LU0417517546.SGD","LU2237443622.USD","LLY","LU2471134523.USD","LU0640476718.USD","LU1548497426.USD","LU1720051017.SGD","SG9999015945.SGD","LU1868836591.USD","LU2236285917.USD","BK4516","LU0006306889.USD","LU0109391861.USD","LU2361045086.USD","LU1280957306.USD","LU0882574055.USD","LU1868837300.USD","LU2089984988.USD","Y","LU2361044865.SGD","LU1069344957.HKD","LU2468319806.SGD","LU0256863902.USD","LU0096364046.USD","LU1061106388.HKD","IE00BJLML261.HKD","LU2552382215.SGD","LU0094547139.USD","LU0385154629.USD","LU1983299246.USD","LU1868836757.USD","LU0061475181.USD","LU2112291526.USD","SG9999015952.SGD","LU2750360997.AUD","LU2456880835.USD","SG9999015978.USD","LU2552382132.HKD","GLP","01276","SGXZ81514606.USD","LU2211815571.USD","LU2461242641.AUD","LU0234572021.USD","SGXZ99366536.SGD","LU0198837287.USD"],"gpt_icon":1},{"id":"2562147775","title":"禮來口服GLP-1藥物orforglipron III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562147775","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562147775?lang=zh_tw&edition=fundamental","pubTime":"2025-08-28 06:04","pubTimestamp":1756332268,"startTime":"0","endTime":"0","summary":"8月26日，礼来公司公布了其在研口服GLP-1受体激动剂orforglipron的III期临床试验ATTAIN-2的积极顶线结果。这项针对合并2型糖尿病的肥胖或超重成人患者的研究表明，orforglipron所有三个剂量组均达到了主要终点和所有关键次要终点。礼来公司表示，随着ATTAIN-2研究的完成，公司已具备向全球监管机构递交orforglipron上市申请所需的全部临床数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828060734a4a359f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250828060734a4a359f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1868837300.USD","LU2237443895.HKD","LU0109391861.USD","LU0094547139.USD","LU1712237335.SGD","LU2237443978.SGD","LU0289739699.SGD","LU1023059063.AUD","LU2108987350.USD","BK4144","LU1917777945.USD","GB00BDT5M118.USD","BK4581","LU2361044865.SGD","LU0417517546.SGD","LU0006306889.USD","LU2211815571.USD","LU1064131342.USD","BK4533","LU0882574139.USD","III","LU1983299246.USD","LU2471134952.CNY","SG9999015945.SGD","SG9999015978.USD","SG9999001176.SGD","LU2417539215.USD","GLP","LU1280957306.USD","LU0106261372.USD","LU1989771016.USD","LU1069344957.HKD","LU1868837136.USD","SGXZ81514606.USD","LU2357305700.SGD","LU2237443382.USD","Y","LLY","LU1291159041.SGD","LU0198837287.USD","IE0004445239.USD","LU0203202063.USD","LU0689472784.USD","LU1868836757.USD","LU0256863811.USD","LU0456855351.SGD","LU1093756325.SGD","LU0823416689.USD","LU2456880835.USD","BK4134"],"gpt_icon":1},{"id":"2562719313","title":"誰在網購減重版GLP-1？京東健康：90後購買量排第一，未來電商渠道預計超過七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2562719313","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562719313?lang=zh_tw&edition=fundamental","pubTime":"2025-08-27 16:20","pubTimestamp":1756282816,"startTime":"0","endTime":"0","summary":"预计2030年GLP-1市场规模将超千亿，在减重市场，互联网电商渠道正成为新的主流，按照今年整体的预期来测算，会占据超过五成市场份额。在未来趋势中，随着电商化愈发成熟，占比会越来越高，预计超过七成。京东健康的数据显示，今年618期间，其平台GLP-1类用药销量同比增长超过3倍。在备受市场关注的GLP-1赛道方面，增速则更加迅速，可以说是指数级增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508271622569500038f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508271622569500038f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4144","BK4231","BK4588","BK4590","O","BK4585","GLP","BK4080"],"gpt_icon":0},{"id":"2562079407","title":"映恩生物上半年調整後利潤1.46億元，現金37.47億元；禮來口服GLP-1一項3期臨牀成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2562079407","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562079407?lang=zh_tw&edition=fundamental","pubTime":"2025-08-27 14:14","pubTimestamp":1756275278,"startTime":"0","endTime":"0","summary":"8月26日，映恩生物公告，上半年总营收12.29亿元，调整后利润1.46亿元，现金总额达到37.47亿元。康诺亚也是在同一天宣布，上半年营收4.99亿元，同比暴增812%，其中包括合作收入3.29亿元。研发支出3.60亿元，同比增长9%。礼来口服GLP-1一项3期临床成功。8月26日，礼来公布了其在研GLP-1受体激动剂orforglipron的3期临床试验ATTAIN-2的积极顶线结果。2）复星医药上半年净利润同比增长38.96%8月26日，复星医药公告，2025年上半年营业收入195.14亿元，净利润17.02亿元，同比增长38.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082714144297641811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082714144297641811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","SG9999018865.SGD","LU2417539215.USD","LU0238689110.USD","LU2746668974.SGD","LU1093756325.SGD","LU2237443549.SGD","LU2089984988.USD","GLP","LU0689472784.USD","LU2471134796.USD","LU0266013472.USD","LU1057294990.SGD","LU1093756168.USD","SGXZ31699556.SGD","LU2491049909.HKD","LU0079474960.USD","LU0820561909.HKD","LU0203202063.USD","LU0823434740.USD","IE00BK4W5M84.HKD","LU2361044949.HKD","SG9999014906.USD","SG9999014898.SGD","LU0323591593.USD","LU0256863811.USD","LU0006306889.USD","LU1061106388.HKD","BK4533","LU2023250504.SGD","LU2361045086.USD","LU1988902786.USD","LU2264538146.SGD","LU0823416689.USD","LU2108987350.USD","Y","LU2112291526.USD","LU0943347566.SGD","LU1366192091.USD","LLY","LU2237443382.USD","IE0004445239.USD","LU1551013342.USD","LU1712237335.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0456855351.SGD","LU2552382058.USD","SG9999013999.USD","LU1551013425.SGD"],"gpt_icon":1},{"id":"2562734782","title":"Viking Therapeutics股價下跌3.8%競爭對手禮來的GLP - 1藥片在糖尿病患者後期研究中助力減輕體重","url":"https://stock-news.laohu8.com/highlight/detail?id=2562734782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562734782?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 21:48","pubTimestamp":1756216116,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0122379950.USD","LU2461242641.AUD","LU2750360641.GBP","LU1868837300.USD","LU2237443465.HKD","LU0096364046.USD","LU2324357040.USD","LU0094547139.USD","LU0109391861.USD","BK4533","LU0114720955.EUR","LU0640476718.USD","LENZ","IE0004445239.USD","LU0708995401.HKD","LU2211815571.USD","LU2264538146.SGD","LU1868836591.USD","LU0466842654.USD","LU0456855351.SGD","IE00BJLML261.HKD","IE00BFTCPJ56.SGD","GLP","LU0820561818.USD","LU0823434583.USD","LU0823434740.USD","LU2023250504.SGD","LU2237443622.USD","LU0823416689.USD","LU1064131342.USD","LU1868836914.USD","LU1720051108.HKD","BK4139","LLY","LU1551013425.SGD","LU1988902786.USD","LU1366192091.USD","LU2089984988.USD","LU0058720904.USD","LU2106854487.HKD","LU1280957306.USD","LU2491050154.USD","LU2237443978.SGD","LU0109394709.USD","IE0002141913.USD","SG9999001176.SGD","LU2750360997.AUD","LU2471134523.USD","SGXZ57979304.SGD","SGXZ99366536.SGD"],"gpt_icon":0},{"id":"2562734322","title":"禮來公司（Eli Lilly）在晚期試驗中發現其GLP - 1片劑使2型糖尿病患者體重減輕10.5%該公司股價上漲3.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2562734322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562734322?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 21:32","pubTimestamp":1756215137,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1562215406f683d19f5eb2345c8cc126","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0889565916.HKD","LU2237443895.HKD","LU0109391861.USD","SGXZ57979304.SGD","LU0094547139.USD","LU2237443622.USD","IE00BK4W5M84.HKD","LU2237443978.SGD","LU0289739699.SGD","LU1023059063.AUD","LU0820561818.USD","LU2552382215.SGD","LU1551013425.SGD","BK4581","BK4516","LU2063271972.USD","LU2324357040.USD","LU0640476718.USD","LU0823434583.USD","LU2211815571.USD","BK4599","SG9999014880.SGD","LU1267930730.SGD","LU2746668461.USD","LU2471134952.CNY","LU2491050154.USD","LU1623119135.USD","LU0109394709.USD","GLP","LU2471134523.USD","LU2461242641.AUD","LU2750360641.GBP","LU2237443465.HKD","SG9999014914.USD","LU1548497426.USD","LU0432979614.USD","LU0079474960.USD","LLY","LU0786609619.USD","LU0882574055.USD","IE0004445239.USD","LU0689472784.USD","LU2491050071.SGD","IE00BK4W5L77.USD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU0256863811.USD","LU0456855351.SGD","LU1093756325.SGD","LU2491049909.HKD"],"gpt_icon":0},{"id":"2562851736","title":"禮來公佈口服GLP-1RA III期臨牀結果，肥胖適應症預計今年在美提交","url":"https://stock-news.laohu8.com/highlight/detail?id=2562851736","media":"时代财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562851736?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 20:06","pubTimestamp":1756209973,"startTime":"0","endTime":"0","summary":"本文来源：时代财经8月26日晚间，时代财经获悉，礼来制药公布了每日一次口服小分子GLP-1受体激动剂orforglipron的III期临床试验ATTAIN-2的积极顶线结果。据悉，礼来计划于2025年向美国食品药品管理局提交 orforglipron用于肥胖症治疗的上市许可申请，并于2026年初针对糖尿病治疗启动申报流程。此外，礼来全球高级副总裁、礼来中国药物开发及医学事务中心负责人王莉博士表示，中国已同步加入了orforglipron的全球研发，期待 orforglipron 能早日在中国获批，为中国患者带来新的治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082620085194fde36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082620085194fde36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0471298777.SGD","LU0320765992.SGD","SGXZ57979304.SGD","LU0256863902.USD","LU0323591593.USD","LU0122379950.USD","LU1868837136.USD","LU0094547139.USD","SG9999014880.SGD","LU0266013472.USD","LU2237443622.USD","LU0058720904.USD","SGXZ99366536.SGD","LU0640476718.USD","LU0354030438.USD","LU2023250504.SGD","GLP","LU1623119135.USD","LU2417539215.USD","LU1232071149.USD","LU1069344957.HKD","LU2360106947.USD","LU2471134952.CNY","LU0203202063.USD","LU0672654240.SGD","LU2211815571.USD","III","SG9999015952.SGD","IE00BK4W5M84.HKD","LU0820561909.HKD","LU2237443895.HKD","SG9999015945.SGD","SGXZ51526630.SGD","LU1974910355.USD","SG9999018865.SGD","LU0471298694.HKD","LU1061106388.HKD","LU2746668974.SGD","SG9999014906.USD","LU0820561818.USD","LLY","LU1366192091.USD","LU2461242641.AUD","SG9999001176.USD","SG9999018857.SGD","LU0882574139.USD","BK4599","SGXZ81514606.USD","BK4144","LU0114720955.EUR"],"gpt_icon":1},{"id":"2562735839","title":"禮來公司週二表示其每日服用的減肥藥丸在後期試驗中幫助肥胖和2型糖尿病患者減輕了體重達到了研究的主要目標為該公司在全球範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2562735839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562735839?lang=zh_tw&edition=fundamental","pubTime":"2025-08-26 19:58","pubTimestamp":1756209527,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1562215406f683d19f5eb2345c8cc126","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2237443622.USD","SG9999014880.SGD","BK4590","LU0323591593.USD","LU0061475181.USD","LU0203201768.USD","LU0097036916.USD","LU0820561818.USD","LU0823434740.USD","LU1868837136.USD","LU2063271972.USD","LU1917777945.USD","LU0096364046.USD","LU0471298694.HKD","IE00BJLML261.HKD","LU0354030511.USD","LU2360106947.USD","SGXZ57979304.SGD","LU0079474960.USD","LU0672654240.SGD","LU2750360641.GBP","LU2106854487.HKD","BK4144","LU1868837300.USD","LU0256863811.USD","LU0316494557.USD","BK4581","LU2491050154.USD","SGXZ51526630.SGD","LU0456855351.SGD","LU1057294990.SGD","LU2491049909.HKD","LU0882574055.USD","LU0466842654.USD","IE00BK4W5M84.HKD","LU1720051017.SGD","LU2237443895.HKD","SG9999015986.USD","LU0820561909.HKD","GLP","LU1804176565.USD","LLY","LU0234572021.USD","LU0320765059.SGD","LU0889565916.HKD","LU2108987350.USD","LU1093756325.SGD","LU2237443465.HKD","NVO","LU1551013342.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":161,"code":"91000000","status":"200"}]}}